Global disease experts say little is known about China's experience with long-term COVID effects thought to have afflicted millions with debilitating fatigue, brain fog and other symptoms
Moderna starts dosing patients in mid-stage coronavirus vaccine study
Moderna Inc said on Friday it had started dosing patients in a mid-stage study with its experimental coronavirus vaccine and eventually plans to enrol 600 patients for the trial.
Published : 30 May 2020, 12:54 PM
Updated : 30 May 2020, 12:54 PM
There are currently about 10 coronavirus vaccines being tested in humans and experts have predicted that a safe and effective vaccine could take 12 to 18 months from the start of development.
Earlier this month, Moderna had released data that showed the vaccine, mRNA-1273, was safe and produced protective antibodies in a small group of healthy volunteers.
The drug developer also reiterated its plans to begin late-stage trials in July.
RELATED STORIES
The demonstrations helped to end COVID restrictions but failed to achieve lasting political change, six participants based in China and overseas say
The agency seeks details on an increase in respiratory illnesses and reported clusters of pneumonia in children, which its China office called a ‘routine’ check
The inquiry is examining the government's response to the coronavirus pandemic that shut large sections of the economy and killed more than 220,000 people in Britain
